Free Trial

BED BATH & BEYOND (NASDAQ:NXH) Stock Rating Cut to "Strong Sell" at Zacks Research

BED BATH & BEYOND logo with background
Image from MarketBeat Media, LLC.

Key Points

  • Zacks Research downgraded Bed Bath & Beyond (NASDAQ: NXH) from “hold” to “strong sell,” while Weiss Ratings assigned a “sell (D-)” rating; the consensus rating is currently “Sell.”
  • The stock opened at $1.83, near its 12-month low of $1.74 versus a high of $12.18. The company reported a quarterly loss of $0.53 per share on $361.16 million in revenue and maintains negative net margins and return on equity.
  • Corient Private Wealth acquired 154,136 shares valued at about $892,000, while institutional investors and hedge funds collectively own 76.3% of the stock. The original Bed Bath & Beyond filed for bankruptcy in 2023 and ceased its retail operations.
  • Five stocks we like better than BED BATH & BEYOND.

BED BATH & BEYOND (NASDAQ:NXH - Get Free Report) was downgraded by equities researchers at Zacks Research from a "hold" rating to a "strong sell" rating in a report released on Monday, Zacks reports.

Separately, Weiss Ratings started coverage on BED BATH & BEYOND in a research report on Friday, August 21st. They set a "sell (d-)" rating on the stock. Two equities research analysts have rated the stock with a Sell rating, According to data from MarketBeat, the company currently has a consensus rating of "Sell".

View Our Latest Research Report on NXH

BED BATH & BEYOND Stock Performance

BED BATH & BEYOND stock opened at $1.83 on Monday. BED BATH & BEYOND has a twelve month low of $1.74 and a twelve month high of $12.18. The company has a debt-to-equity ratio of 0.06, a quick ratio of 0.59 and a current ratio of 0.76. The stock has a market capitalization of $174.76 million, a PE ratio of -1.61 and a beta of 3.01.

BED BATH & BEYOND (NASDAQ:NXH - Get Free Report) last announced its earnings results on Tuesday, August 4th. The company reported ($0.53) earnings per share (EPS) for the quarter. The business had revenue of $361.16 million for the quarter. BED BATH & BEYOND had a negative net margin of 7.13% and a negative return on equity of 37.60%. As a group, equities analysts forecast that BED BATH & BEYOND will post -0.93 EPS for the current year.

Hedge Funds Weigh In On BED BATH & BEYOND

An institutional investor recently bought a new position in BED BATH & BEYOND stock. Corient Private Wealth LP acquired a new position in BED BATH & BEYOND, INC. (NASDAQ:NXH - Free Report) during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor acquired 154,136 shares of the company's stock, valued at approximately $892,000. Corient Private Wealth LP owned 0.16% of BED BATH & BEYOND at the end of the most recent reporting period. Institutional investors and hedge funds own 76.30% of the company's stock.

About BED BATH & BEYOND

(Get Free Report)

Bed Bath & Beyond was a U.S. home-goods retailer that operated stores and an e-commerce platform offering bedding, bath products, kitchenware, home décor, furniture, storage solutions and related household merchandise. The company served consumers primarily in the United States and Canada through its flagship Bed Bath & Beyond stores and affiliated concepts, including buybuy BABY and Harmon.

The original Bed Bath & Beyond Inc filed for bankruptcy protection in 2023 and subsequently ceased operating its retail business.

Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in BED BATH & BEYOND Right Now?

Before you consider BED BATH & BEYOND, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and BED BATH & BEYOND wasn't on the list.

While BED BATH & BEYOND currently has a Sell rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 Best Stocks to Own in Fall 2026 Cover

AI spending is reshaping the market, and the opportunity extends far beyond the biggest chipmakers. Discover 10 stocks set to benefit from powerful trends in AI infrastructure, cloud computing, energy, capital returns, and consumer growth this fall.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines